Sunteți pe pagina 1din 24

Cystic Fibrosis

PATIENT CARE PRESENTATION

NICOLE BRUNNE
100613938
PCAR * 4302
MARCH 11TH 2018 Picture: (Fandom, 2016)
Table of contents

1. Cystic Fibrosis Condition Overview


2. Patient Overview
 Past History
 Location of treatment
 Signs/Symptoms
 Stage of CF
 Safety Precautions/or contraindications for treatment
 Current medical management
 Rehab plan
 FITT principle
What is Cystic Fibrosis/CF?
 Most common genetic disease that is life threatening
 affecting Canadian children and young adults
 CF affects the digestive system and lungs
 Causes mucus in body to become thick/sticky
 Mucus builds up and affects organs
 Severity differs from patient to patient
 Infections in the lungs, destruction of lungs and loss of lung function
 Reason for majority of deaths in CF patients
 Complication with CF
 Difficulty digesting fats/proteins
 Inability to absorb nutrients sufficiently
 CF related diabetes
 Sinus infections
(Cystic Fibrosis Canada, 2018)
Causes of CF
 Genetic disease
 Autosomal Recessive disease
 Occurs when a child inherits two abnormal
genes, one from each parent
 The parents are carriers only and do not
have CF or exhibit any symptoms
 When both parents are carriers
 25 % chance the child with be born with CF, 50
% the child will be a carrier, 25 % child will be
born neither
 Females with CF have greater deterioration of Picture: (Cystic Fibrosis Canada, 2018)
pulmonary function with increasing age and a
younger mean age of death

(Cystic Fibrosis Canada, 2018)


Pathophysiology of CF
 Defects in the cystic fibrosis gene
 Codes for a protein transmembrane conductance
regulator(CFTR)
 Functions as a chloride channel and regulated by
cAMP
 Mutations of CFTR results in abnormalities of cAMP-
regulated chloride transport
 Defective CFTR results in:
 Decreased secretion of chloride and increased
reabsorption of Na and H20 across epithelial cells
 Mucus is than more stickier for bacteria to adhere
 Staphylococcus aureus, haemophilus influenzae and
aeruginosa are common bacterial infections (Al-Nemrawi
et al, 2018)
 Secretions become thicker as well and become Picture: (British Columbia Respiratory Therapy, 2015)

difficult to clear from system


(Sharma, 2018)
In the lungs..

 Thicker than normal mucus forms in airways


 Breathing problems
 Mucus traps bacteria and this can lead to
 Frequent lungs infections
 Permanent lung damage
 Trouble “getting air in”
 Obstructive lung disease

Picture: (National Lung, Heart and Blood Institute, 2018)


(Healthwise Staff, 2017)
In the pancreas..

 Mucus blockages can affect normal


digestive processes
 Increased risk for infections
 Harder to absorb nutrients from food
 Lower than normal body weight and
development
 Difficulty gaining weight

Picture: (Healthwise Staff, 2017)

(Healthwise Staff, 2017)


Symptoms of CF
 Multi-symptom disorder
 Persistent cough with thick mucous
 SOB
 Chest infections, may lead to pneumonia
 Bowel disturbances
 Weight loss/hard time gaining weight
 Salty sweat
 Infertility for men
 Decreased fertility for women
Picture: (Mayo Clinic, 2016)

 Pulmonary involvement occurs in 90% of


CF patients
 End stage lung disease is the primary
COD (Cystic Fibrosis Canada, 2018)
Diagnosing CF
 If child is suspected to have CF
 Doctor will perform a “sweat test”
 Test measures the amount of salt content present in the sweat
 Median age of diagnosis is between 6-8 months of age
 Genetic testing, prenatal and newborn screenings can be done to diagnose CF
 If not diagnosed at birth, watch for:
 Diarrhea, not growing/gaining weight, breathing problems that do not go way, wheezing,
clubbing, rectal prolapse, polyps in nose/sinuses
 Imaging that is helpful with for diagnosis
 Radiography, CT of chest, Ultrasonography, Contrast barium edema

(Sharma, 2018)
Prognosis

 Life expectancy for individuals with CF


 Steadily increasing
 On average live to mid 30’s
 New treatments have helped individuals live
into their 40’s or longer
 Individuals with a mild form may live a normal
life expectancy
 Individuals may need a lung transplant
during the progression of the disease

Picture: (Healthwise Staff, 2017)

(Healthwise Staff, 2017)


Treatments/Therapy

 No cure
 Management of CF focuses on treating respiratory and digestive
problems to prevent infections or secondary complications
 Treatment combines medications, home treatments like respiratory therapy,
and nutritional therapy
 Depends on the symptoms the patient presents with
 Different treatments are used to relieve different symptoms
 Lung function tests can be used to monitor progression
 Therapy
 Respiratory therapy
 Digestive therapy
 Postural drainage

(Healthwise Staff, 2017)


Respiratory Therapy

 Any treatment that slows down lung damage


 Improves breathing
 Used to rid of mucus and bacteria in lungs
 Mechanical equipment used:
 High frequency chest compression vest
 Positive expiratory pressure therapy (PEP)
 Techniques used
 Airway clearance techniques
 Postural drainage with chest percussions
Picture: (Cystic Fibrosis Foundation, 2018)
 Deep breathing exercises to build up strength of respiratory muscles
 Coughing
 Aerobic exercise
 Helps to loosen mucus, encourages coughing, improves O2 flow

(Healthwise Staff, 2017)


Digestive Therapy

 Replaces certain digestive enzymes


 Creon or Ultrase
 Helps to ensure nutrients and minerals are digested properly
 Individuals usually change their diet:
 Taking in high caloric foods, high fat foods, nutritional drinks, feeding tube

(Healthwise Staff, 2017)


Interdisciplinary Team

 GP
 Pediatrician
 Respirologist
 Internist
 Gastroenterologist
 RT
 PT
 Social Worker
 Pharmacist
 Psychologist

(Healthwise Staff, 2017)


Exacerbation Warning Signs
 CF individuals loose/are unable to absorb salt effectively
 Careful to always supplement salt intake during:
 Exercise
 On hot days
 Warning Signs
 ↑ cough
 ↑ sputum production
 Fever
 Weight loss
 ↑ RR &/or WOB
 New wheezing/crackles
 ↓ exercise tolerance
 ↓ FEV1 of >10% over 3 months
 ↓ 02 saturation of >10% over 3 months
 New findings on chest x-ray

(Maybury, March 9, 2018)


Patient Overview
Patient Overview: Lily
 Patient name : Lily Davis
 Age: 7 years old
 Weight: 50lbs
 Gender: Female
 Diagnosed after birth
 CF classified at mild
 Current medical status mild CF to recent exacerbation of CF with increase in mucus and
secretions in airways
 Parents are carriers of CF gene
 Mother is a nurse, Father works for the military
 Only child
 Lives in bungalow with swimming pool and swing set
 Lives 10 minutes from school
 Recently more interested in diagnosis and wants to understand therapy
 Loves to swim, play soccer, use swing set, likes to do yoga with mom
Medical History

 Hospitalized at 4 yo
 feeding tube surgically placed
 Regular visits to SickKids for lung function tests, blood tests
 Previously had lung scan at 2 yo
 Recently diagnosed with mild form of ADHD
Current Medical Management

 Uses PAP medical treatment for lungs 2 times a day


 Morning at 6am and night at 7pm
 Takes Ultrase for digestive therapy
 Takes with every meal (Healthwise Staff, 2017)
 Parents looking to start airway clearance techniques daily
Current Symptoms

 SOB with long periods of physical activity or excitement


 Persistent cough
 Recently increased mucus and secretions, rough cough
 Below average weight for children her age
 Salty sweat
Safety Considerations for Patient

 Monitor for excessive SOB or mucus production throughout session


 Monitor vitals: HR, RR
 Watch for fatigue or exhaustion when first starting rehab program
 Have oxygen near by for emergency
 Infection control critical
 “Cepacia +”
 Hand-washing and appropriate sanitization of equipment is critical to
avoid passing between patients
 Avoid treatment immediately following meals
 Aerosol therapy medications prior to manual chest physiotherapy
 Energy conservation
(Maybury, March 9, 2018)
Rehab Plan

 Therapy visits: Lily to attend 4 sessions at SickKids Hospital with parents to


educate on airway clearance techniques and introducing FITT plan
 Therapy sessions will be planned for 11am which is after lily’s respiratory
therapy in the morning
 Airway clearance techniques
 Taught to parents to do daily
 Postural drainage of upper and lower lobe of R and L lung, with 5 minutes of
percussions (each position), 2 minutes of vibrations (each position), followed
by 2 coughs after each position
 total of 20-25 minutes of therapy (Maybury, February, 12, 2018)
 FITT principle
 Will include warm up, aerobic exercise, cool down, stretching, strengthening
(Maybury, January 29, 2018)
FITT M-S Mon. Tues. Wed. Thurs. Friday Saturday Sunday M-S
Rehab Warm-up Cool-
Plan Down
Frequency 2X/d 2X/d 2X/d 2X/d 2X/d 2X/d 2X/d 2X/d 2X/d
7 days/w 7 days/w 7 days/w 7 days/w 7 days/w 7 days/w 7 days/w 7 days/w 7 days/w

Intensity 106 (220-7)-80 (220-7)-80 X (220-7)-80 X .40 (220-7)-80 X (220-7)-80 X (220-7)-80 X (220-7)-80 X 106 bpm
bpm X .40 + 80= .40 + 80= 133 + 80= 133bpm .40 + 80= .40 + 80= .40 + 80= .40 + 80=
133 bpm 133 133bpm 133bpm 133bpm
bpm bpm

Time 10 min. 60 min/d 60 min/d 60 min/d 60 min/d 60 min/d 60 min/d 60 min/d 10 min.
Split up Split up into Split up into 20 & Split up into Split up into Split up into Split up into
into 20 & 20 & 40 min 40 min 20 & 40 min 20 & 40 min 20 & 40 min 20 & 40 min
40 min

Type Jumping Aerobic Aerobic Aerobic Aerobic Aerobic Strengthenin Strengthenin Hop Scotch
Jacks Walking to Walking to Walking to Walking to Walking to g: g:
school= school= school= school= school= Throwing 1lbs Throwing 1lbs
20min, 20min, 20min, 20min, 20min, ball back & ball back &
After After school After school After school After school forth=20min, forth=20min,
school sports sports group= sports sports group= Swimming=40 Swimming=40
sports group= 40min group= 40min min min
group= 40min (Gymnastics) 40min (swimming)
40min (swimming) (soccer)
(soccer)

Stretching/ Kids Yoga-15 Kids Yoga-


Flexibility minutes 15 Minutes
References
Pictures:
Sources:
Al-Newrawi, N., Alshraiedeh, N., Zayed, A., and Altaani, B. (2018).
Low molecular weight chitosan-coated PLGA nanoparticles for British Columbia Respiratory Therapy. (2015). Cystic fibrosis hope as new gene therapy
pulmonary delivery of tobramycin for cystic fibrosis. Journal of improves condition. Retrieved from http://bcrt.ca/cystic-fibrosis-hope-as-new-gene-
Pharmaceuticals. 11(1). Retrieved from http://www.mdpi.com/1424- therapy-improves-condition/
8247/11/1/28/htm
Cystic Fibrosis Canada. (2018). What is cystic fibrosis. Retrieved from
Cystic Fibrosis Canada. (2018). What is cystic fibrosis. Retrieved from http://www.cysticfibrosis.ca/about-cf/what-is-cystic-fibrosis
http://www.cysticfibrosis.ca/about-cf/what-is-cystic-fibrosis
Cystic Fibrosis Foundation. (2018). Airway Clearance. Retrieved from
https://www.cff.org/Life-With-CF/Treatments-and-Therapies/Airway-Clearance/
Healthwise Staff. (2017). Cystic Fibrosis. Retrieved from
https://myhealth.alberta.ca/Health/pages/conditions.aspx?hwid=h Healthwise Staff. (2017). Cystic Fibrosis. Retrieved from
w188548 https://myhealth.alberta.ca/Health/pages/conditions.aspx?hwid=hw188548

Fandom. (2016). Cystic fibrosis lungs. Retrieved from


Maybury, L. (2018, January 29). PTOT 4304 Course Lecture. http://fragile.wikia.com/wiki/File:Cystic-Fibrosis-Lungs-Pictures-3.jpg

National Lung, Heart and Blood Institute. (2018). Cross-sections of a healthy airway
(top) and an airway affected by cystic fibrosis (bottom). Retrieved from
Maybury, L. (2018, February 12). PTOT 4304 Course Lecture. https://www.hopkinsmedicine.org/research/advancements-in-
research/fundamentals/in-depth/piecing-together-cystic-fibrosis

Maybury, L. (2018, March 9). PCAR 4302 Course Lecture. Mayo Clinic. (2016). Cystic fibrosis. Retrieved from
https://www.mayoclinic.org/diseases-conditions/cystic-fibrosis/symptoms-causes/syc-
20353700
Sharma, G. (2018). Cystic fibrosis. Retrieved from
https://emedicine.medscape.com/article/1001602-overview#a3

S-ar putea să vă placă și